A LONGITUDINAL STUDY OF LEPTIN AND APPETITE, RESTING ENERGY EXPENDITURE AND BODY FAT MASS IN WEIGHT-STABLE CANCER PATIENTS

Cytokine ◽  
2002 ◽  
Vol 20 (4) ◽  
pp. 174-177 ◽  
Author(s):  
Roma Maguire ◽  
Donald C McMillan ◽  
A.Michael Wallace ◽  
Colin McArdle
2008 ◽  
Vol 101 (4) ◽  
pp. 474-477 ◽  
Author(s):  
Anja Bosy-Westphal ◽  
Manfred J. Müller ◽  
Michael Boschmann ◽  
Susanne Klaus ◽  
Georg Kreymann ◽  
...  

Body fat mass (FM) adds to the variance in resting energy expenditure (REE). However, the nature and extent of this relationship remains unclear. Using a database of 1306 women and a linear regression model, we systematically analysed the contribution of FM to the total variance in REE at different grades of adiposity (ranges of body %FM). After adjusting for age, the relative contribution of FM on REE variance increased from low ( ≤ 10 %FM) to normal (>10– ≤ 30 %FM) and moderately elevated (>30– ≤ 40 %FM) grades of adiposity but decreased sharply at high (>40– ≤ 50 %FM) and very high (>50 %FM) grades of adiposity according to the ratio between regression coefficients. These data suggest that the specific metabolic rate of fat tissue is reduced at high adiposity. This should be considered when REE is normalized for FM in obesity.


2018 ◽  
Vol 19 (10) ◽  
pp. 3281 ◽  
Author(s):  
Youngmi Lee ◽  
Eun-Young Kwon ◽  
Myung-Sook Choi

Isoliquiritigenin (ILG) is a flavonoid constituent of Glycyrrhizae plants. The current study investigated the effects of ILG on diet-induced obesity and metabolic diseases. C57BL/6J mice were fed a normal diet (AIN-76 purified diet), high-fat diet (40 kcal% fat), and high-fat diet +0.02% (w/w) ILG for 16 weeks. Supplementation of ILG resulted in decreased body fat mass and plasma cholesterol level. ILG ameliorated hepatic steatosis by suppressing the expression of hepatic lipogenesis genes and hepatic triglyceride and fatty acid contents, while enhancing β-oxidation in the liver. ILG improved insulin resistance by lowering plasma glucose and insulin levels. This was also demonstrated by the intraperitoneal glucose tolerance test (IPGTT). Additionally, ILG upregulated the expression of insulin signaling-related genes in the liver and muscle. Interestingly, ILG elevated energy expenditure by increasing the expression of thermogenesis genes, which is linked to stimulated mitochondrial biogenesis and uncoupled cellular respiration in brown adipose tissue. ILG also suppressed proinflammatory cytokine levels in the plasma. These results suggest that ILG supplemented at 0.02% in the diet can ameliorate body fat mass, plasma cholesterol, non-alcoholic fatty liver disease, and insulin resistance; these effects were partly mediated by increasing energy expenditure in high-fat fed mice.


1984 ◽  
Vol 199 (3) ◽  
pp. 292-298 ◽  
Author(s):  
JEFFREY M. ARBEIT ◽  
DAVID E. LEES ◽  
ROLAND CORSEY ◽  
MURRAY F. BRENNAN

1992 ◽  
Vol 56 (5) ◽  
pp. 848-856 ◽  
Author(s):  
K M Nelson ◽  
R L Weinsier ◽  
C L Long ◽  
Y Schutz

Sign in / Sign up

Export Citation Format

Share Document